retatrutide trials results First phase 3 data, a Triumph of Science! Lilly's 'triple G' agonist triumphs

thelancet.com Look, M., et al

10.1016/j.ajpath.2012.10.014 29 GuoH.GuoQ.LiZ.WangZ

Retatrutide works like other weight loss and type 2 diabetes medications, but what makes it different is that it can target three receptors (triple agonist) at once: Gastric inhibitory polypeptide receptor (GIP) Glucagon-like peptide-1 receptor (GLP-1) Glucagon receptors (GCG) This unique triple-action may make it more effective than GLP-1 and GLP-1/GIP medications

Eligibility Its important to ensure that Ozempic will be beneficial for you before you start treatment

ISBN 9781416031154

If you have ever had an allergic reaction to a medicine